ANDA 84272, held by Sandoz. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 84272 (Butabarbital Sodium), held by Sandoz, was not approved, with 12 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium30MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
| Aug 16, 1985 | Supplement 75Manufacturing | Approved | None posted |
| Jun 5, 1984 | Supplement 73Manufacturing | Approved | None posted |
| Jun 5, 1984 | Supplement 72Manufacturing | Approved | None posted |
| Jul 26, 1983 | Supplement 71Manufacturing | Approved | None posted |
| Jul 26, 1983 | Supplement 70Manufacturing | Approved | None posted |
| May 16, 1983 | Supplement 69Manufacturing | Approved | None posted |
| May 5, 1983 | Supplement 67Manufacturing | Approved | None posted |
| Nov 26, 1982 | Supplement 66Manufacturing | Approved | None posted |
| Dec 22, 1981 | Supplement 63Manufacturing | Approved | None posted |
| Dec 22, 1981 | Supplement 62Manufacturing | Approved | None posted |
| Dec 22, 1981 | Supplement 61Manufacturing | Approved | None posted |
| Dec 22, 1981 | Supplement 60Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters